Through its MammoView instrument line
Solos Endoscopy (Solos), in the closing months of 2009, has taken the initial steps to obtain the CE Mark for its MammoView line of surgical endoscopy instruments.
This will allow the MammoView line to be sold throughout the European Economic Union (EEU), which according to a 2009 report published by Frost & Sullivan, represents $94b or 30% of the worldwide demand for medical instruments.
Solos’ focus is to strengthen its domestic market share in the industry through the implementation of several strategies in 2010. In addition, Solos will continue building product awareness and has retained the services of Advertising Associates International to manage its 2010 marketing, promotional and advertising campaign.
Finally, the company plans to expand its research and development efforts to develop new instrumentation to better assist the physician primarily in the area of breast endoscopy.
Bob Segersten, president of Solos Endoscopy, said: “We are excited about the progress that Solos has made in 2009. We look forward to increasing our sales revenues with the implementation of our product awareness campaign while at the same time increasing our research and development efforts.”